Showing results (51-60 of 190) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2022
Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600-Mutant Low-Grade GliomaEric Bouffet, Birgit Geoerger, Christopher Moertel, et al.
European Journal of Cancer (Oxford, England : 1990)|October 29, 2011
Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcomaBirgit Geoerger, Mark W Kieran, Stephan Grupp, et al.
Pediatric Blood & Cancer|May 26, 2006
Do medulloblastoma tumors meet the Food and Drug Administration criteria for anti-erbB2 therapy with trastuzumab?Natacha Entz-Werle, Valérie Velasco, Agnès Neuville, et al.
JCO Precision Oncology|January 11, 2024
Precision Medicine for Childhood Cancer: Current Limitations and Future PerspectivesMartin G McCabe, Birgit Geoerger, Louis Chesler, et al.
Neuron|March 15, 2020
Whole-Neuron Synaptic Mapping Reveals Spatially Precise Excitatory/Inhibitory Balance Limiting Dendritic and Somatic SpikingDaniel Maxim Iascone, Yujie Li, Uygar Sümbül, et al.
Frontiers in Oncology|December 12, 2019
A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of RhabdomyosarcomasSusanne A Gatz, Ewa Aladowicz, Michela Casanova, et al.
Neuron|December 1, 2014
Signaling switch of the axon guidance receptor Robo3 during vertebrate evolutionPavol Zelina, Heike Blockus, Yvrick Zagar, et al.
Cancer Medicine|February 24, 2018
Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG miceMaria Eugenia Marques da Costa, Estelle Daudigeos-Dubus, Anne Gomez-Brouchet, et al.
The Journal of Gene Medicine|January 15, 2005
Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastomaBirgit Geoerger, Victor W van Beusechem, Paule Opolon, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2011
A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: an Innovative Therapies for Children with Cancer (ITCC) studyBirgit Geoerger, Edward J Estlin, Isabelle Aerts, et al.
Pageof 19